Skip to content

Relation of Blood-boron Levels With Body Mass Index

Phase 1 Study of Blood Boron Levels According to Body Mas Index

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01400061
Enrollment
80
Registered
2011-07-22
Start date
2011-08-31
Completion date
2011-12-31
Last updated
2011-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Keywords

obesity, etiology, pathogenesis, treatment

Brief summary

According to our experimental experiences w hypothesized that blood boron levels may be corralated to body mass index.

Detailed description

In the results of our experimental study on mices we revealed that low dose oral boric acid intake cause seriously body mas reducing. Although blood and urine analyses support high glucose, lipid and middle protein catabolisms, but the mechanism was unclear. There are some diseases according to blood elementary deficiencies, like hypothyroidi in hypoiyodinemia, hiperparathyroidi in hypocalcemia, etc. We hypothesised that hypoboronemia may be corralated to body mass index level.

Interventions

None listed

Sponsors

SB Istanbul Education and Research Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* body mas index levels in over 19 peoples

Exclusion criteria

* known chronic, morbid and malign diseases

Design outcomes

Primary

MeasureTime frameDescription
blood boron level6 monthsblood boron levels will be measured cantitatively

Secondary

MeasureTime frameDescription
body mass index6 monthsbody mass index levels will be evaluated with blood boron levels

Countries

Turkey (Türkiye)

Contacts

Primary Contacterhan aysan, assoc. prof.
+902124531700
Backup Contactgokhan cipe, MD
+902124531700

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026